ENSPRYNG
ENSPRYNG
Approved
DIN Number
02499681
Drug Class
Human
Market Date
Aug 26, 2020
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02499681
AIG Number0162294001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AC19 SATRALIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification92:20.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
SATRALIZUMABActive
Strength: 120 MG / ML
Monograph: SATRALIZUMAB